Particle.news

Download on the App Store

Serena WilliamsGLP-1 Endorsement Triggers Backlash and Conflict-of-Interest Questions

Health commentators warn that celebrity promotion could normalize medicalized weight loss.

Overview

  • Williams said she used a GLP-1 regimen via telehealth provider Ro and lost more than 31 pounds after her second pregnancy.
  • Ro promoted a paid partnership with Williams in a joint Instagram post that showed her administering a weekly injection.
  • Public reaction turned sharply critical, with Jameela Jamil warning about serious side effects and unequal access tied to celebrity promotion.
  • Regulators note that some GLP-1 drugs are FDA-approved for weight management and carry risks such as gastrointestinal problems and pancreatitis, with warnings issued against unapproved versions.
  • Observers flagged a potential conflict because her husband, Alexis Ohanian, serves on Ro’s board, alongside concerns about high costs and widening disparities.